Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Kodiak Sciences Inc.KOD · Entity 4388 | Chief Financial Officer | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Kodiak Sciences Inc.
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.42 · Expires 2036-07-14 | Direct | 66,500 |
Reported balance
After 2026-07-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 66,500 · Balance 66,500 F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2026; the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 Equity Incentive Plan) as of each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2026; the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 Equity Incentive Plan) as of each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 17, 2026 20:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 66,500 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001754045-26-000008 · form4-07172026_080713.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,500 Underlying: Common Stock · 66,500 shares Expires 2036-07-14 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2026; the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 Equity Incentive Plan) as of each vesting date. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001754045-26-000006 · form4-06052026_090646.xml · derivative · entry 4 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2026-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option are fully vested. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 4,104 | $34.67 | $142,285.68 |
DisclosureSEC source: 0001754045-26-000006 · form4-06052026_090646.xml · nonDerivative · entry 3 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,930 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $34.49 to $35.05, inclusive. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 25,896 | $34.01 | $880,722.96 |
DisclosureSEC source: 0001754045-26-000006 · form4-06052026_090646.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,034 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $33.49 to $34.48, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 30,000 | $1.04 | $31,200.00 |
DisclosureSEC source: 0001754045-26-000006 · form4-06052026_090646.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 241,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 21:00 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 28,614 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001754045-26-000004 · form4-04162026_090412.xml · derivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 28,614 shares Expires 2026-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to this option are fully vested. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 21:00 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 28,614 | $1.04 | $29,758.56 |
DisclosureSEC source: 0001754045-26-000004 · form4-04162026_090412.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 00:26 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001754045-26-000002 · form4-04032026_120417.xml · derivative · entry 6 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,614 Underlying: Common Stock · 30,000 shares Expires 2026-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to this option are fully vested. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 00:26 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 600 | $41.77 | $25,062.00 |
DisclosureSEC source: 0001754045-26-000002 · form4-04032026_120417.xml · nonDerivative · entry 5 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 183,316 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $41.69 to $41.91, inclusive. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 00:26 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 4,231 | $40.88 | $172,963.28 |
DisclosureSEC source: 0001754045-26-000002 · form4-04032026_120417.xml · nonDerivative · entry 4 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 183,916 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $40.68 to $41.67, inclusive. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 00:26 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 12,477 | $40.29 | $502,698.33 |
DisclosureSEC source: 0001754045-26-000002 · form4-04032026_120417.xml · nonDerivative · entry 3 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,147 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $39.68 to $40.67, inclusive. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 00:26 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 12,692 | $39.14 | $496,764.88 |
DisclosureSEC source: 0001754045-26-000002 · form4-04032026_120417.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,624 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $38.68 to $39.67, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 00:26 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 30,000 | $1.04 | $31,200.00 |
DisclosureSEC source: 0001754045-26-000002 · form4-04032026_120417.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 04, 2025 Filed Jul 8, 2025 20:33 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001415889-25-019517 · form4-07082025_080719.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2035-07-03 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2025; the balance of the Shares vest in a series of forty-seven (47) successive equal monthly installments thereafter, subject to Reporting Person's Continuous Service (as defined in the 2018 Equity Incentive Plan) as of each such date. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 00:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 723 | $3.65 | $2,639.67 |
DisclosureSEC source: 0001415889-25-017624 · form4-06182025_120604.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,316 F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2025. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 15, 2025 Filed Jun 18, 2025 00:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017624 · form4-06182025_120604.xml · derivative · entry 3 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2025 Filed Jun 18, 2025 00:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 1,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-017624 · form4-06182025_120604.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:52 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 334,500 | $0.00 Strike: $2.49 | $0.00 |
DisclosureSEC source: 0001415889-24-020925 · form4-08072024_080839.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,500 Underlying: Common Stock · 334,500 shares Expires 2034-08-04 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2024; the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 Equity Incentive Plan) as of each vesting date. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 21:00 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,874 | $2.75 | $7,903.50 |
DisclosureSEC source: 0001415889-24-017449 · form4-06182024_090649.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,164 F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2024. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 21:00 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-017449 · form4-06182024_090649.xml · derivative · entry 4 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F4 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F4 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 21:00 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-017449 · form4-06182024_090649.xml · derivative · entry 3 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,619 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 21:00 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 5,494 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-017449 · form4-06182024_090649.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 20:39 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,558 | $2.92 | $4,549.36 |
DisclosureSEC source: 0001415889-24-016682 · form4-06132024_080636.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 179,544 F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 11, 2024. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:39 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016682 · form4-06132024_080636.xml · derivative · entry 3 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs vested in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs vested in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:39 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 3,025 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-016682 · form4-06132024_080636.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| June 24, 2023 Filed Jun 27, 2023 21:32 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 207,500 | $0.00 Strike: $7.24 | $0.00 |
DisclosureSEC source: 0001209191-23-039940 · doc4.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,500 Underlying: Common Stock · 207,500 shares Expires 2033-06-23 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 16, 2023 Filed Jun 17, 2023 00:25 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,749 | $9.23 | $25,373.27 |
DisclosureSEC source: 0001209191-23-038165 · doc4.xml · nonDerivative · entry 3 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,077 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2023. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:25 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038165 · doc4.xml · derivative · entry 5 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock. F5 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F5 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:25 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038165 · doc4.xml · derivative · entry 4 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,619 Underlying: Common Stock · 3,619 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock. F4 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F4 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2023 Filed Jun 17, 2023 00:25 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 5,494 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-038165 · doc4.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| June 14, 2023 Filed Jun 17, 2023 00:25 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,448 | $9.42 | $13,640.16 |
DisclosureSEC source: 0001209191-23-038165 · doc4.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,332 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units ("RSU") on June 11, 2023. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 21:30 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-036828 · doc4.xml · derivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,025 Underlying: Common Stock · 3,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F2 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F2 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 21:30 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 3,025 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-036828 · doc4.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 21:21 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 142,500 | $0.00 Strike: $8.15 | $0.00 |
DisclosureSEC source: 0001209191-22-041687 · doc4.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,500 Underlying: Common Stock · 142,500 shares Expires 2032-07-05 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 17, 2022 Filed Jun 17, 2022 23:54 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,798 | $7.02 | $19,641.96 |
DisclosureSEC source: 0001209191-22-038176 · doc4.xml · nonDerivative · entry 3 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,755 F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2022. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 23:54 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038176 · doc4.xml · derivative · entry 5 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F5 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F5 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 23:54 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038176 · doc4.xml · derivative · entry 4 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,238 Underlying: Common Stock · 3,619 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F4 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F4 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 23:54 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,545 | $7.21 | $11,139.45 |
DisclosureSEC source: 0001209191-22-038176 · doc4.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,553 F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 11, 2022. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 23:54 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 5,494 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-038176 · doc4.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| June 11, 2022 Filed Jun 15, 2022 00:30 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036832 · doc4.xml · derivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,050 Underlying: Common Stock · 3,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the RSUs vested on June 11, 2021, upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the RSUs will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2022 Filed Jun 15, 2022 00:30 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 3,025 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-036832 · doc4.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F2 · balance_after: Includes 136 shares acquired under the 2018 Employee Stock Purchase Plan on November 30, 2021. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 22:12 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $131.44 | $0.00 |
DisclosureSEC source: 0001209191-22-011371 · doc4.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-20 F1 · derivative.exercise_date: On February 21, 2021, the Reporting Person was awarded a performance-based option. 1/4th of the shares subject to the option vested on February 16, 2022 upon the achievement of certain performance criteria (the "Performance Criteria Achievement Date"); thereafter, the shares subject to the option will vest in thirty-six (36) successive equal monthly installments measured from the Performance Criteria Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:55 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 204 | $116.29 | $23,724.16 |
DisclosureSEC source: 0001209191-21-064246 · doc4.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,443 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $116.29 to $116.625, inclusive. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:55 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 672 | $115.16 | $77,386.38 |
DisclosureSEC source: 0001209191-21-064246 · doc4.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,647 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $115.00 to $115.95, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 22:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051485 · doc4.xml · derivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the restricted stock units vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the restricted stock units vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 22:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Purchase) · Derivative | 50,000 | $0.00 Strike: $88.21 | $0.00 |
DisclosureSEC source: 0001209191-21-051485 · doc4.xml · derivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-08-12 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after the Vesting Commencement Date (June 30, 2021); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 15, 2021 Filed Jun 15, 2021 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,037 | $84.75 | $87,885.75 |
DisclosureSEC source: 0001209191-21-040739 · doc4.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,990 F3 · kind: The sale was made to cover tax withholding obligations in connection with vesting and settlement of 1/4th of the Reporting Person's performance-based RSU granted on December 30, 2019. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 01:24 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041807 · doc4.xml · derivative · entry 3 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,857 Underlying: Common Stock · 3,619 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the RSU vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the RSU vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 01:24 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,290 | $80.90 | $104,361.00 |
DisclosureSEC source: 0001209191-21-041807 · doc4.xml · nonDerivative · entry 2 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,319 F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 01:24 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 3,619 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-041807 · doc4.xml · nonDerivative · entry 1 BORGESON JOHN A. · CIK 0001754045 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.